新型冠状病毒感染(COVID-19)与心血管系统疾病
Coronavirus Disease 2019 (COVID-19) and Cardiovascular System Diseases
摘要: 新型冠状病毒感染(COVID-19)是一种急性呼吸系统传染性疾病，目前已证实其可累及全身多个系统，除肺组织外，以心血管系统受累最为常见，主要表现为心肌损伤、心律失常、急性心肌炎、心肌病、心力衰竭及急性心肌梗死。有基础心血管疾病者合并新型冠状病毒感染后重症发生比例更高，死亡风险更大。现对新型冠状病毒肺炎命名及其心血管系统常见并发症进行综述。
Abstract: Coronavirus Disease 2019 (COVID-19) is an acute respiratory infectious disease that has been shown to involve multiple systems throughout the body. In addition to the lungs, the cardiovascular system is most commonly affected, with myocardial injury, arrhythmias, acute myocarditis, cardio-myopathy, heart failure and acute myocardial infarction. People with underlying cardiovascular disease have a higher rate of severe illness and a greater risk of death after developing Coronavirus Disease 2019 (COVID-19). The origin of COVID-19 nomenclature and common complications of car-diovascular system are described.
文章引用：高秀秀, 吴胜军. 新型冠状病毒感染(COVID-19)与心血管系统疾病[J]. 临床医学进展, 2023, 13(10): 15717-15723. https://doi.org/10.12677/ACM.2023.13102198

参考文献

[1] 新型冠状病毒感染诊疗方案(试行第十版) [J]. 心肺血管病杂志, 2023, 42(1): 1-8.
[2] 罗晓君, 章文贤. 冠状病毒的结构及生物学特性概述[J]. 生物学教学, 2020, 45(7): 4-6.
[3] Desingu, P.A., Nagarajan, K. and Dhama, K. (2022) Emergence of Omicron Third Lineage BA.3 and Its Importance. Journal of Medical Virology, 94, 1808-1810. [Google Scholar] [CrossRef] [PubMed]
[4] 中华人民共和国国家卫生健康委员会宣传司. 国务院联防联控机制2022年4月28日新闻发布会文字实录[EB/OL]. http://www.nhc.gov.cn/xcs/s3574/202204/ 34ce2f4566844cee9c0b2f0a5afbf6f7.shtml, 2022-04-28.
[5] 中华人民共和国国家卫生健康委员会. 关于新型冠状病毒肺炎更名为新型冠状病毒感染的公告 公告2022年第7号[J]. 中国医药, 2023, 18(1): 5.
[6] Zhu, N., Zhang, D., Wang, W., et al. (2020) A Novel Coronavirus from Patients with Pneumonia in China, 2019. New England Journal of Medicine, 382, 727-733. [Google Scholar] [CrossRef] 
[7] 魏星. 新型冠状病毒及其感染的疾病名称[J]. 中国科技术语, 2020, 22(1): 60.
[8] 赛岱安. 新型冠状病毒及新冠肺炎英文名确定[J]. 中国科技翻译, 2020, 33(1): 55+24+36. [Google Scholar] [CrossRef] 
[9] 周烨真, 张世豪, 陈嘉仪, 等. 新型冠状病毒SARS-CoV-2的变异和进化分析[J]. 南方医科大学学报, 2020, 40(2): 152-158.
[10] 国家卫生健康委员会官方网站. 国家卫生健康委关于修订新型冠状病毒肺炎英文命名事宜的通知[EB/OL]. http://www.nhc.gov.cn/xcs/zhengcwj/202002/6ed7614bc35244cab117d5a03c2b4861.shtml, 2020-02-22.
[11] 李雷, 彭祎雪, 张洁, 等. 新型冠状病毒对心血管系统影响的研究进展[J]. 中国胸心血管外科临床杂志, 2022, 29(1): 106-113.
[12] Li, J.-W., Han, T.-W., Woodward, M., et al. (2020) The Impact of 2019 Novel Coronavirus on Heart Injury: A Systematic Review and Meta-Analysis. Progress in Cardiovascular Diseases, 63, 518-524. [Google Scholar] [CrossRef] [PubMed]
[13] Zhou, B., She, J., Wang, Y. and Ma, X. (2020) The Clinical Char-acteristics of Myocardial Injury in Severe and Very Severe Patients with 2019 Novel Coronavirus Disease. Journal of Infection, 81, 147-178. [Google Scholar] [CrossRef] [PubMed]
[14] Guo, T., Fan, Y., Chen, M., et al. (2020) Cardiovascular Implica-tions of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19). JAMA Cardiology, 5, 811-818. [Google Scholar] [CrossRef] [PubMed]
[15] 周灵, 刘辉国. 新型冠状病毒肺炎患者的早期识别和病情评估[J]. 中华结核和呼吸杂志, 2020(3): 167-170.
[16] Wang, D., Hu, B., Hu, C., et al. (2020) Clinical Characteris-tics of 138 Hospitalized Patients with 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 323, 1061-1069. [Google Scholar] [CrossRef] [PubMed]
[17] Bhatla, A., Mayer, M.M., Adusumalli, S, et al. (2020) COVID-19 and Cardiac Arrhythmias. Heart Rhythm, 17, 1439- 1444. [Google Scholar] [CrossRef] [PubMed]
[18] Wu, C.-I., Postema, P.G., Arbelo, E., et al. (2020) SARS-CoV-2, COVID-19, and Inherited Arrhythmia Syndromes. Heart Rhythm, 17, 1456-1462. [Google Scholar] [CrossRef] [PubMed]
[19] Bonow, R.O., Fonarow, G.C., O’Gara, P.T. and Yancy, C.W. (2020) Association of Coronavirus Disease 2019 (COVID-19) with Myocardial Injury and Mortality. JAMA Cardiology, 5, 751-753. [Google Scholar] [CrossRef] [PubMed]
[20] Xu, Z., Shi, L., Wang, Y., et al. (2020) Pathological Findings of COVID-19 Associated with Acute Respiratory Distress Syndrome. The Lancet Respiratory Medicine, 8, 420-422. [Google Scholar] [CrossRef] 
[21] Inciardi, R.M., Lupi, L., Zaccone, G., et al. (2020) Cardiac Involvement in a Patient with Coronavirus Disease 2019 (COVID-19). JAMA Cardiology, 5, 819-824. [Google Scholar] [CrossRef] [PubMed]
[22] Hua, A., O’Gallagher, K., Sado, D. and Byrne, J. (2020) Life-Threatening Cardiac Tamponade Complicating Myo-Peri- carditis in COVID-19. European Heart Journal, 41, 2130. [Google Scholar] [CrossRef] [PubMed]
[23] Minhas, A.S., Scheel, P., Garibaldi, B., et al. (2020) Takotsubo Syndrome in the Setting of COVID-19. JACC: Case Reports, 2, 1321-1325. [Google Scholar] [CrossRef] [PubMed]
[24] Chadha, S. (2020) ‘COVID-19 Pandemic’ Anxiety-Induced Ta-kotsubo Cardiomyopathy. QJM: An International Journal of Medicine, 113, 488-490. [Google Scholar] [CrossRef] [PubMed]
[25] Zhou, F., Yu, T., Du, R., et al. (2020) Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. Lancet, 395, 1054-1062. [Google Scholar] [CrossRef] 
[26] Chen, T., Wu, D., Chen, H., et al. (2020) Clinical Character-istics of 113 Deceased Patients with Coronavirus Disease 2019: Retrospective Study. BMJ, 368, Article No. m1091. [Google Scholar] [CrossRef] [PubMed]
[27] Rey, J.R., Caro-Codón, J., Rosillo, S.O., et al. (2020) Heart Failure in COVID-19 Patients: Prevalence, Incidence and Prognostic Implications. European Journal of Heart Failure, 22, 2205-2215. [Google Scholar] [CrossRef] [PubMed]
[28] Guzik, T.J., Mohiddin, S.A., Dimarco, A., et al. (2020) COVID-19 and the Cardiovascular System: Implications for Risk Assessment, Diagnosis, and Treatment Options. Car-diovascular Research, 116, 1666-1687. [Google Scholar] [CrossRef] [PubMed]
[29] Bangalore, S., Sharma, A., Slotwiner, A., et al. (2020) ST-Segment Ele-vation in Patients with Covid-19—A Case Series. New England Journal of Medicine, 382, 2478-2480. [Google Scholar] [CrossRef] 
[30] Stefanini, G.G., Montorfano, M., Trabattoni, D., et al. (2020) ST-Elevation Myocardial Infarction in Patients with COVID-19: Clinical and Angiographic Outcomes. Circulation, 141, 2113-2116. [Google Scholar] [CrossRef] 
[31] Tam, C.-C.F., Cheung, K.-S., Lam, S., et al. (2021) Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on Outcome of Myocardial Infarction in Hong Kong, China. Catheterization and Cardiovascular Interventions, 97, E194- E197. [Google Scholar] [CrossRef] [PubMed]
[32] Zhu, H., Rhee, J.-W., Cheng, P., et al. (2020) Correction to: Cardiovascular Complications in Patients with COVID-19: Conse-quences of Viral Toxicities and Host Immune Response. Current Cardiology Reports, 22, Article No. 36. [Google Scholar] [CrossRef] [PubMed]

为你推荐